
ABCL vs ERAS
$ABCL vs $ERAS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABCL vs ERAS: trend, levels and the market
One year to 2026-11-16, against the S&P 500 (+11.2%). Split-adjusted daily closes.
- ·Both trends are mixed, above one moving average and below the other, which is how a stock looks while it changes direction.
- ·Both beat the market over the past year: ABCL +209% and ERAS +426%, against the S&P 500 at +11.2%.
- ·ABCL sits closer to its support, 4% above it at $10.68, while ERAS is 6.1% above its own at $14.19.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ABCL vs ERAS: the quick read
- ·ERAS is the larger company by market cap ($5.50B vs $3.75B).
- ·ERAS has been more active on our scanner (174 vs 169 alerts in 30 days).
- ·ABCL has the smaller float (233.6M vs 305.1M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 174 and 169 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 46% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching ABCL or ERAS? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABCL and ERAS on TheDesperateTrader.
- Is ABCL or ERAS the better stock?
- "Better" depends on your goal, and these two are not alike. ERAS is the larger company by market cap ($5.50B vs $3.75B). ERAS has been more active on our scanner (174 vs 169 alerts in 30 days). ABCL has the smaller float (233.6M vs 305.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABCL and ERAS?
- The differences that matter: they are similar in size ($3.75B vs $5.50B); they trade at very different share prices ($11.13 vs $15.11); ABCL sits at 68% of its 52-week range against 58% for ERAS; our scanner flagged ABCL 169 times in the last 30 days against 174 for ERAS. Everything above is measured from the latest completed session and SEC filings.
- Which of ABCL and ERAS is more active right now?
- Right now ABCL is at about 0.6x its normal volume and ERAS is at about 1.6x, so ERAS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ABCL or ERAS in the stronger trend?
- ABCL is below its 50-day average of $12.33 and above its 200-day average of $7.27; ERAS is above its 50-day average of $14.94 and below its 200-day average of $15.28. ERAS leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABCL or ERAS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ABCL and ERAS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.